Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France

Paul D. Robbins; Christian Jorgensen; Christopher H. Evans

doi:10.1186/ar317

Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France

Paul D. Robbins, Christian Jorgensen, Christopher H. Evans

Physical Medicine and Rehabilitation

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

The field of gene therapy for bone and joint disorders has grown considerably over the last two and a half years. Investigators have shown that ex vivo or in vivo gene transfer is highly effective in blocking arthritis or facilitating repair of damaged cartilage or bone. The feasibility of applying gene therapy for the treatment of arthritis in humans has also been demonstrated. Thus, gene therapy appears poised to make significant contributions to the clinical treatment of joint and bone diseases in the near future.

Original language	English (US)
Pages (from-to)	289-292
Number of pages	4
Journal	Arthritis Research
Volume	3
Issue number	5
DOIs	https://doi.org/10.1186/ar317
State	Published - 2001

Keywords

Arthritis
Bone
Cartilage
Clinical trial
Gene therapy
Vector

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1186/ar317

Cite this

@article{10ecc7f1fd6b443da6789c2c090dcf6e,

title = "Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France",

abstract = "The field of gene therapy for bone and joint disorders has grown considerably over the last two and a half years. Investigators have shown that ex vivo or in vivo gene transfer is highly effective in blocking arthritis or facilitating repair of damaged cartilage or bone. The feasibility of applying gene therapy for the treatment of arthritis in humans has also been demonstrated. Thus, gene therapy appears poised to make significant contributions to the clinical treatment of joint and bone diseases in the near future.",

keywords = "Arthritis, Bone, Cartilage, Clinical trial, Gene therapy, Vector",

author = "Robbins, {Paul D.} and Christian Jorgensen and Evans, {Christopher H.}",

year = "2001",

doi = "10.1186/ar317",

language = "English (US)",

volume = "3",

pages = "289--292",

journal = "Arthritis Research",

issn = "1465-9905",

publisher = "BioMed Central",

number = "5",

}

TY - JOUR

T1 - Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France

AU - Robbins, Paul D.

AU - Jorgensen, Christian

AU - Evans, Christopher H.

PY - 2001

Y1 - 2001

N2 - The field of gene therapy for bone and joint disorders has grown considerably over the last two and a half years. Investigators have shown that ex vivo or in vivo gene transfer is highly effective in blocking arthritis or facilitating repair of damaged cartilage or bone. The feasibility of applying gene therapy for the treatment of arthritis in humans has also been demonstrated. Thus, gene therapy appears poised to make significant contributions to the clinical treatment of joint and bone diseases in the near future.

AB - The field of gene therapy for bone and joint disorders has grown considerably over the last two and a half years. Investigators have shown that ex vivo or in vivo gene transfer is highly effective in blocking arthritis or facilitating repair of damaged cartilage or bone. The feasibility of applying gene therapy for the treatment of arthritis in humans has also been demonstrated. Thus, gene therapy appears poised to make significant contributions to the clinical treatment of joint and bone diseases in the near future.

KW - Arthritis

KW - Bone

KW - Cartilage

KW - Clinical trial

KW - Gene therapy

KW - Vector

UR - http://www.scopus.com/inward/record.url?scp=0034856103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034856103&partnerID=8YFLogxK

U2 - 10.1186/ar317

DO - 10.1186/ar317

M3 - Article

AN - SCOPUS:0034856103

SN - 1465-9905

VL - 3

SP - 289

EP - 292

JO - Arthritis Research

JF - Arthritis Research

IS - 5

ER -

Gene therapy moves forward - The Second International Meeting on Gene and Cell Therapies of Arthritis and Related Disorders, 17-18 May 2001, Montpellier, France

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this